BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

524506

CORALAB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

CORAL LABORATORIES LTD. Share Price Update

As of the latest trading session, CORAL LABORATORIES LTD. share price is currently at ₹ 646, which is down by ₹ -8.79 from its previous closing. Today, the stock has fluctuated between ₹ 632.00 and ₹ 664.00. Over the past year, CORAL LABORATORIES LTD. has achieved a return of 70.58 %. In the last month alone, the return has been -6.96 %. Read More...

CORAL LABORATORIES LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    230.60

  • P/E Ratio (TTM)

    8.62

  • Beta

    1.11

  • Book Value / share

    570.15

  • Return on equity

    9.50%

  • EPS (TTM)

    76.14

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    6.14

info icon alternate text

CORAL LABORATORIES LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 22.99
Operating Expense 17.20
Net Profit 6.14
Net Profit Margin (%) 26.70
Earnings Per Share (EPS) 17.20
EBITDA 8.83
Effective Tax Rate (%) 26.11
Particulars SEP 2024 (Values in Cr)
Revenue 32.23
Operating Expense 26.24
Net Profit 6.38
Net Profit Margin (%) 19.79
Earnings Per Share (EPS) 17.86
EBITDA 9.04
Effective Tax Rate (%) 25.20
Particulars JUN 2024 (Values in Cr)
Revenue 31.66
Operating Expense 21.44
Net Profit 8.80
Net Profit Margin (%) 27.79
Earnings Per Share (EPS) 24.64
EBITDA 12.29
Effective Tax Rate (%) 25.23
Particulars MAR 2024 (Values in Cr)
Revenue 28.89
Operating Expense 23.14
Net Profit 5.79
Net Profit Margin (%) 20.04
Earnings Per Share (EPS) 16.20
EBITDA 8.24
Effective Tax Rate (%) 25.32
Particulars DEC 2023 (Values in Cr)
Revenue 18.08
Operating Expense 16.47
Net Profit 2.16
Net Profit Margin (%) 11.94
Earnings Per Share (EPS) 6.04
EBITDA 3.46
Effective Tax Rate (%) 27.51
Particulars MAR 2024 (Values in Cr)
Revenue 83.66
Operating Expense 69.40
Net Profit 15.79
Net Profit Margin (%) 18.87
Earnings Per Share (EPS) 44.19
EBITDA 22.71
Effective Tax Rate (%) 23.83
Particulars MAR 2023 (Values in Cr)
Revenue 78.12
Operating Expense 76.83
Net Profit 6.45
Net Profit Margin (%) 8.25
Earnings Per Share (EPS) 18.04
EBITDA 10.75
Effective Tax Rate (%) 21.62
Particulars MAR 2022 (Values in Cr)
Revenue 75.61
Operating Expense 69.53
Net Profit 9.05
Net Profit Margin (%) 11.96
Earnings Per Share (EPS) 25.32
EBITDA 13.99
Effective Tax Rate (%) 23.69
Particulars MAR 2021 (Values in Cr)
Revenue 96.57
Operating Expense 82.74
Net Profit 13.55
Net Profit Margin (%) 14.03
Earnings Per Share (EPS) 37.94
EBITDA 19.63
Effective Tax Rate (%) 23.05
Particulars MAR 2020 (Values in Cr)
Revenue 70.58
Operating Expense 67.36
Net Profit 7.13
Net Profit Margin (%) 10.10
Earnings Per Share (EPS) 19.96
EBITDA 11.19
Effective Tax Rate (%) 21.82
Particulars MAR 2024 (Values in Cr)
Book Value / Share 496.83
ROE % 9.50
ROCE % 12.26
Total Debt to Total Equity 0.00
EBITDA Margin 27.15
Particulars MAR 2023 (Values in Cr)
Book Value / Share 433.29
ROE % 4.15
ROCE % 5.23
Total Debt to Total Equity 0.02
EBITDA Margin 13.76
Particulars MAR 2022 (Values in Cr)
Book Value / Share 436.81
ROE % 6.18
ROCE % 7.70
Total Debt to Total Equity 0.04
EBITDA Margin 18.50
Particulars MAR 2021 (Values in Cr)
Book Value / Share 382.48
ROE % 10.74
ROCE % 13.28
Total Debt to Total Equity 0.05
EBITDA Margin 20.34
Particulars MAR 2020 (Values in Cr)
Book Value / Share 323.77
ROE % 6.22
ROCE % 7.83
Total Debt to Total Equity 0.03
EBITDA Margin 16.02
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 61.28
Total Assets 205.68
Total Liabilities 205.68
Total Equity 177.49
Share Outstanding 3572600
Price to Book Ratio 0.75
Return on Assets (%) 7.67
Return on Capital (%) 8.9
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 40.40
Total Assets 174.34
Total Liabilities 174.34
Total Equity 154.79
Share Outstanding 3572600
Price to Book Ratio 0.53
Return on Assets (%) 3.69
Return on Capital (%) 4.16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 37.47
Total Assets 189.89
Total Liabilities 189.89
Total Equity 156.05
Share Outstanding 3572600
Price to Book Ratio 0.58
Return on Assets (%) 4.76
Return on Capital (%) 5.58
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 34.82
Total Assets 167.53
Total Liabilities 167.53
Total Equity 136.64
Share Outstanding 3572600
Price to Book Ratio 0.84
Return on Assets (%) 8.09
Return on Capital (%) 9.49
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 29.99
Total Assets 144.28
Total Liabilities 144.28
Total Equity 115.67
Share Outstanding 3572600
Price to Book Ratio 0.30
Return on Assets (%) 4.94
Return on Capital (%) 5.86
Particulars MAR 2024 (Values in Cr)
Net Income 20.89
Cash from Operations -0.57
Cash from Investing 1.39
Cash from Financing 0.00
Net change in Cash -4.05
Free Cash Flow 0.41
Particulars MAR 2023 (Values in Cr)
Net Income 8.18
Cash from Operations 14.63
Cash from Investing -2.61
Cash from Financing -6.42
Net change in Cash 3.62
Free Cash Flow 16.57
Particulars MAR 2022 (Values in Cr)
Net Income 10.89
Cash from Operations 10.45
Cash from Investing -6.05
Cash from Financing 0.14
Net change in Cash 0.18
Free Cash Flow 16.00
Particulars MAR 2021 (Values in Cr)
Net Income 17.59
Cash from Operations 4.35
Cash from Investing -0.06
Cash from Financing 0.35
Net change in Cash 1.21
Free Cash Flow 5.71
Particulars MAR 2020 (Values in Cr)
Net Income 9.11
Cash from Operations -3.20
Cash from Investing -1.55
Cash from Financing 3.55
Net change in Cash -1.85
Free Cash Flow -1.82
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 19.95 2.02 284.31 34.11 / 77.70
BLISS GVS PHARMA LTD 122.65 16.07 1.27 1292.37 92.25 / 184.95
CIPLA LTD 1541.00 24.94 4.38 124457.39 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 272.25 22.56 2.76 801.26 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2904.45 57.61 29.41 49203.14 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 22.35 6.30 284.31 34.11 / 77.70
AMRUTAJAN HEALTH LTD 679.10 39.81 6.59 1963.32 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8795.90 131.18 32.36 21989.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 122.65 15.93 1.26 1292.37 92.25 / 184.95

CORAL LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
646.00 -1.34 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 670.70
  • 26 Days 694.20
  • 10 Days 676.70
  • 50 Days 716.40
  • 12 Days 678.70
  • 100 Days 739.10
  • 20 Days 687.50
  • 200 Days 719.30
662.38 PIVOT

First Support

646.42

First Resistance

670.77

Second Support

638.03

Second Resistance

686.73

Third Support

622.07

Third Resistance

695.12

RSI

39.58

ADX

58.71

MACD

-15.52

Williams % R

-68.39

Commodity Channel Index (CCI)

-68.22

Date

2025-04-29

Week

1692.00

Same Day

1390.00

Month

1252.00

1 Year

1.11

3 Year

0.74

Over 1 Month

-6.96%

down

Over 1 Year

70.58%

down

Over 3 Months

-13.12%

down

Over 3 Years

34.26%

down

Over 6 Months

-19.41%

down

Over 5 Years

34.57%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

CORAL LABORATORIES LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
28.48%
Promoter Holdings
71.51%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Chetan Navinchandra Doshi 1841453.0 (51.54%) Shareholding of Promoter and Promoter Group
Coral India Finance And Housing Ltd. 713351.0 (19.97%) Shareholding of Promoter and Promoter Group
Meeta Samir Sheth 65890.0 (1.84%) Public Shareholding
Pooja Bhagwandas 55909.0 (1.56%) Public Shareholding
Noetic Finance Private Limited 37630.0 (1.05%) Public Shareholding
Navinchandra Bachubhai Doshi 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kundan Navinchandra Doshi 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

CORAL LABORATORIES LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2019 2.0 Final 21 Sep 2019 Equity shares
18 Sep 2018 2.0 Final 21 Sep 2018 Equity shares
11 Sep 2017 5.0 Final 13 Sep 2017 Equity shares
16 Sep 2016 3.0 Final 20 Sep 2016 Equity shares
08 Sep 2015 2.5 Final 10 Sep 2015 Equity shares
16 Sep 2014 2.0 Final 18 Sep 2014 Equity shares
18 Sep 2013 1.5 Final 20 Sep 2013 Equity shares
17 Sep 2012 1.5 Final 19 Sep 2012 Equity shares
19 Sep 2011 1.5 Final 21 Sep 2011 Equity shares
17 Sep 2010 1.5 Final 21 Sep 2010 Equity shares
17 Sep 2009 1.2 Final 22 Sep 2009 Equity shares
19 Sep 2008 1.0 Final 23 Sep 2008 Equity shares
20 Sep 2007 1.5 Final 24 Sep 2007 Equity shares
20 Sep 2005 0.0 Final 22 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

CORAL LABORATORIES LTD. Share Price

Coral Laboratories Limited (CLL) was established in February, 1997. Carol Labs are into manufacturing of Generic Branded, Nutraceuticals, OTC and Herbal Medicines. The Company produces various pharmaceutical formulations in 3 different locations all over India. It has plants at Daman and Dehradun .

The Company was promoted by Navin B Doshi of the DWD group. To manufacture pharmaceutical formulations like tablets, capsules, liquid and topical preparation, the Company went into public issue in March 94 at a total cost of Rs.2.5 crores. It setup an additional ultra-modern manufacturing unit at Daman and the said Unit started the commercial production during March 2004. It started the commercial production at Dehradun Plant in September, 2006.

Parent organization Coral
NSE symbol [-]
Founded 1981
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Coral Laboratories Ltd?

Answer Field

The share price of Coral Laboratories Ltd for NSE is ₹ 0.00 and for BSE is ₹ 646.00.

What is the Market Cap of Coral Laboratories Ltd?

Answer Field

The market cap of Coral Laboratories Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 2,30.60 Cr. as of now.

What is the 52 Week High and Low of Coral Laboratories Ltd?

Answer Field

The 52 Week High and Low of Coral Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 999.00 and ₹ 355.00.

How to Buy Coral Laboratories Ltd share?

Answer Field

You can trade in Coral Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Coral Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 70.58%.

What is the Current Share Price of Coral Laboratories Ltd?

Answer Field

Coral Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 646.00 as on Apr 30 2025 03:22 PM.

What is the Market Cap of Coral Laboratories Ltd Share?

Answer Field

The market cap of Coral Laboratories Ltd for NSE ₹ 0.0 & for BSE ₹ 2,30.60 as on Apr 30 2025 03:22 PM.

What is the P/E Ratio of Coral Laboratories Ltd Share?

Answer Field

As on Apr 30 2025 03:22 PM the price-to-earnings (PE) ratio for Coral Laboratories Ltd share is 8.62.

What is the PB ratio of Coral Laboratories Ltd Share?

Answer Field

As on Apr 30 2025 03:22 PM, the price-to-book (PB) ratio for Coral Laboratories Ltd share is 570.15.

How to Buy Coral Laboratories Ltd Share?

Answer Field

You can trade in Coral Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Coral Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Coral Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Coral Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|